Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Goldman Sachs
New York
| $410M | -$33.6M | 27 | 0.1% | Reduced |
|
| 27 |
Manning & Napier Advisors
Fairport,
New York
| $377M | -$31.6M | 1 | 3.23% | Reduced |
|
| 28 |
BBA
Baker Bros. Advisors
New York
| $374M | -$25.4M | 12 | 3.03% | Reduced |
|
| 29 |
Invesco
Atlanta,
Georgia
| $362M | +$10.2M | 14 | 0.13% | Increased |
|
| 30 |
JP Morgan Chase
New York
| $351M | -$41M | 26 | 0.08% | Reduced |
|
| 31 |
Bank of New York Mellon
New York
| $340M | +$10.8M | 35 | 0.09% | Increased |
|
| 32 |
Thomaspartners
Boston,
Massachusetts
| $311M | +$6.56M | 1 | 2.49% | Increased |
|
| 33 |
EARNEST Partners
Atlanta,
Georgia
| $303M | -$1.1M | 3 | 3.02% | Reduced |
|
| 34 |
Dimensional Fund Advisors
Austin,
Texas
| $301M | -$5.71M | 15 | 0.13% | Reduced |
|
| 35 |
Millennium Management
New York
| $281M | +$26.3M | 28 | 0.43% | Increased |
|
| 36 |
Capital International Investors
Los Angeles,
California
| $280M | +$30.8M | 2 | 0.34% | Increased |
|
| 37 |
Geode Capital Management
Boston,
Massachusetts
| $267M | +$26.8M | 41 | 0.1% | Increased |
|
| 38 |
Aristotle Capital Management
Los Angeles,
California
| $256M | -$731K | 1 | 1.99% | Reduced |
|
| 39 |
OrbiMed
New York
| $242M | +$28.1M | 6 | 2.31% | Increased |
|
| 40 |
Norges Bank
Oslo,
Norway
| $235M | -$35.1M | 9 | 0.09% | Reduced |
|
| 41 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $235M | +$75M | 40 | 0.16% | Increased |
|
| 42 |
Capital World Investors
Los Angeles,
California
| $233M | +$14.5M | 4 | 0.05% | Increased |
|
| 43 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $229M | +$4.9M | 1 | 1.95% | Increased |
|
| 44 |
SCCM
Schafer Cullen Capital Management
New York
| $227M | -$11.5M | 1 | 2.73% | Reduced |
|
| 45 |
OppenheimerFunds
New York
| $225M | +$39.7M | 6 | 0.28% | Increased |
|
| 46 |
Eagle Asset Management
St Petersburg,
Florida
| $221M | +$80.2M | 9 | 1.27% | Increased |
|
| 47 |
D.E. Shaw & Co
New York
| $211M | +$2.78M | 20 | 0.32% | Increased |
|
| 48 |
Sands Capital Management
Arlington,
Virginia
| $207M | -$8.95M | 1 | 0.62% | Reduced |
|
| 49 |
Lord, Abbett & Co
Jersey City,
New Jersey
| $202M | +$90M | 5 | 0.59% | Increased |
|
| 50 |
Brown Advisory
Baltimore,
Maryland
| $202M | -$3.65M | 5 | 0.67% | Reduced |
|